Bahrain vs South Sudan: Access to anti-retroviral drugs, male
Bahrain
53.0%
in 2024
South Sudan
52.0%
in 2024
Bahrain rank
112th
South Sudan rank
113th
Access to anti-retroviral drugs, male over time
- Bahrain
- South Sudan
How they compare
Bahrain currently reports 53.0% against 52.0% in South Sudan, a difference of 1.0%.
Across all 25 years both countries report, Bahrain has been ahead every year.
Bahrain ranks 112th and South Sudan ranks 113th of 141 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.9% | 0.1% | 9.8% | Bahrain |
| 2010s | 30.1% | 10.0% | 20.1% | Bahrain |
| 2020s | 52.2% | 39.4% | 12.8% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bahrain or South Sudan?
- Bahrain, at 53.0% against 52.0% in South Sudan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bahrain and South Sudan?
- 1.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and South Sudan?
- 25 years are reported by both, from 2000 to 2024.
- How do Bahrain and South Sudan rank globally for access to anti-retroviral drugs, male?
- Bahrain ranks 112th and South Sudan ranks 113th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.